JPRN-UMIN000030598已完成2 期
Docetaxel plus Ramucirumab with pegylated granulocyte-colony stimulating factor support for elderly patients with advanced non-small cell lung cancer: A multicenter prospective single arm phase II study: DRAGON study(WJOG9416L) - DOC+RAM+PEG-G-CSF in elderly NSCLC
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active multiple cancer 2) Active infection 3) Interstitial pneumonia/pulmonary fibrosis 4) Uncontrolled diabetes 5) Uncontrolled hypertension 6) Clinically significant heart failure or uncontrolled arythmia 7) Ileus, inflammatory bowel disease, or chronic diarrhea 8) Uncontrolled thromboembolism 9) HIV associated disease 10) Severe psychological disease 11) Severe liver dysfunction such as cirrhosis 12) Prescription of steroids and/or immunosuppressant 13) Anticoaglation with warfarin or heparin 14) Prescription of long-term NSAIDS or antiplatelets 15) Fever >= 38.0 degrees C 16) Recent history of hemoptysis 17) Recent history of cardio-brain vascular disease 18) Incurable wound, ulcer, or bone fracture 19) Recent history of bleeding, vasculitis, or gastrointestinal hemorrhage 20) Recent history of gastrointestinal perforation/fistula 21) History of hypersensitivity by agents containing polysorbate 80 22) Plan of major surgery during the trial
研究者
相似试验
已完成
2 期
Docetaxel plus Ramucirumab with pegylated granulocyte-colony stimulating factor support for elderly patients with advanced non-small cell lung cancer: A multicenter prospective single arm phase II study (WJOG9416L)non-small cell lung cancerNon-small cell lung cancerJPRN-jRCTs051180232Hata Akito65
进行中（未招募）
2 期
Docetaxel plus Ramucirumab immediately after treatment with ICInon-small cell lung cancer, adenocarcinoma, squamous cell carcinomanon-small cell lung cancerJPRN-jRCT1051190091Akamatsu Hiroaki35
已完成
不适用
Phase II study of ramucirumab plus docetaxel plus pegfilgrastim with stage IV non-small cell lung cancer patientsnon-small cell lung cancerJPRN-UMIN000025972Gunma University20
进行中（未招募）
不适用
Docetaxel plus Atezolizumab plus Herceptin SC and Pertuzumab for Patients with Early Breast Cancer and Atezolizumab plus Herceptin SC and Pertuzumab chemotherapy after SurgeryKCT0003774Samsung Medical Center67
已完成
2 期
Phase II trial of docetaxel plus ramucirumab combination therapy in patients with advanced EGFR gene mutation positive advanced stage non-squamous cell nonsmall cell lung cancer (HSR 1701)non-small cell lung cancerJPRN-UMIN000030603Second Division, Department of Internal Medicine, Hamamatsu university school of medicine35